Concepedia
Statistics
Publications
2
Citations
109
H-Index
Active since
2017
Affiliations
Novartis (Switzerland)(Current)
Kelli‐Ann Monaco is an author at Novartis (Switzerland).
Publications per year
2017–2020
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
Kelli‐Ann Monaco, Scott Delach, Jing Yuan et al. · Clinical Cancer Research · 2020 · 84 citations · Full text
BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity
Kelli‐Ann Monaco, Ping Wang, Marissa N. Balak et al. · Molecular Cancer Research · 2017 · 25 citations
1–2 of 2